focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,812.50
Bid: 1,812.50
Ask: 1,813.00
Change: 2.50 (0.14%)
Spread: 0.50 (0.028%)
Open: 1,811.00
High: 1,820.00
Low: 1,803.00
Prev. Close: 1,812.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

What to know about bird flu in dairy cows and the risk to humans

Wed, 03rd Apr 2024 21:37

CHICAGO, April 3 (Reuters) - Texas officials reported on Monday that a farm worker tested positive for H5N1, or bird flu, that has spread to dairy cows in Texas, Kansas, New Mexico, Michigan and Idaho - the first time the virus has infected cattle.

Health officials and scientists say the risk to humans remains low, but many questions remain.

IS BIRD FLU A CONCERN?

The Texas case is only the second time bird flu has been confirmed in a human in the United States, with the first occurring in 2022 in Colorado in a person exposed to infected poultry. In both cases, the infections were mild.

The Texas farm worker's only symptom was conjunctivitis, or pink eye. He is being treated with Tamiflu, which is used to treat human influenza.

The infections are from the same subtype of bird flu that has been infecting wild birds and poultry flocks globally for more than two years, also killing several mammal species that likely contracted the virus from consuming sick or dead birds.

WHAT ARE THE RISKS OF BIRD FLU?

Some outbreaks of avian influenza have caused serious or fatal infections among people who have close contact with wild birds or poultry. Currently, H5N1 is not capable of spreading easily among humans, but scientists have been on alert for changes that could facilitate human spread and spark a pandemic.

Dr. Thomas Inglesby, director of the Johns Hopkins Center for Health Security, said the Texas case "doesn't change the overall risk of a major pandemic," but stressed that any new case should be investigated to ensure it is not spreading from person to person.

An official with the U.S. Centers for Disease Control and Prevention (CDC) said for most people who are not exposed to infected animals, the risk is very low.

The CDC has analyzed the genetic sequences of the virus in the infected cattle and the dairy worker and determined that they lack changes that would make it better adapted to be transmitted among mammals.

DOES BIRD FLU AFFECT THE FOOD SUPPLY?

The risk of contaminated milk reaching consumers is of "no concern" according to the U.S. Department of Agriculture because pasteurization kills viruses and milk from sick cows is not being sold.

The CDC renewed its warning that people should not consume raw milk or cheese, which can contain a number of pathogens.

At this point, no beef cattle are known to have been infected with the virus.

IS THERE A BIRD FLU VACCINE FOR HUMANS?

The U.S. has a stockpile of bird flu vaccines matched with the strain currently circulating, as well as antivirals that could be used to treat human infections, Inglesby said. If there were a major epidemic or a pandemic, the U.S. would have to scale up "in a huge way," he said.

The CDC has sample or "seed" strains of virus that manufacturers could use to make more vaccine that closely matches the circulating virus, an official said.

Flu vaccine suppliers Sanofi, GlaxoSmithKline and CSL Seqirus said in statements they are monitoring avian flu and stand ready to develop avian flu vaccines as needed.

HOW WERE THE COWS INFECTED WITH H5N1?

Richard Webby, a virologist at St. Jude's Children's Research Hospital in Memphis, Tennessee, said it is still not clear how the cows became infected, how many have been infected or how the virus has spread to other herds, but said there's "reasonable evidence that there has been some cow-to-cow spread." (Reporting by Julie Steenhuysen Editing by Caroline Humer and Bill Berkrot)

More News
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.